Abstract
Expression of inducible NO synthase (iNOS) by macrophages is a prerequisite for the production of high output NO, which mediates many bactericidal and tumoricidal actions of these immune cells. The expression of iNOS in mammalian cells is governed predominantly by the transcription factor, NF-kappa B, which regulates the expression of many host defense proteins. In the present study, we characterize a novel, biphasic effect of NO on NF-kappa B activity in murine macrophages. This mechanism depends on the local concentration of NO and enables it both to up- and down-regulate the expression of host defense proteins including iNOS, cyclooxygenase-2, and IL-6. This biphasic activity of NO appears to play a pivotal role in the time course of activation of these immune cells and, by inference, in facilitating the initiation of a defense response against pathogenic stimuli and in its termination to limit tissue damage. This mechanism may explain at least in part the reported ability of NO to act in both a pro- and anti-inflammatory manner.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / antagonists & inhibitors
-
Anti-Inflammatory Agents, Non-Steroidal / metabolism
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Anti-Inflammatory Agents, Non-Steroidal / toxicity
-
Arginine / pharmacology
-
Cell Line
-
Cell Survival / drug effects
-
Cell Survival / immunology
-
Culture Media
-
Cyclooxygenase 2
-
Drug Combinations
-
Drug Synergism
-
Hydrazines / pharmacology
-
Inflammation Mediators / antagonists & inhibitors
-
Inflammation Mediators / metabolism
-
Inflammation Mediators / pharmacology
-
Inflammation Mediators / physiology*
-
Interleukin-6 / antagonists & inhibitors
-
Interleukin-6 / biosynthesis
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / biosynthesis
-
Isoenzymes / genetics
-
Lipopolysaccharides / immunology
-
Macrophage Activation / drug effects
-
Macrophage Activation / immunology
-
Macrophages / drug effects
-
Macrophages / enzymology
-
Macrophages / immunology
-
Macrophages / metabolism
-
Mice
-
NF-kappa B / antagonists & inhibitors
-
NF-kappa B / metabolism*
-
NG-Nitroarginine Methyl Ester / pharmacology
-
Nitric Oxide / antagonists & inhibitors
-
Nitric Oxide / biosynthesis
-
Nitric Oxide / pharmacology
-
Nitric Oxide / physiology*
-
Nitric Oxide Synthase / antagonists & inhibitors
-
Nitric Oxide Synthase / biosynthesis
-
Nitric Oxide Synthase / genetics
-
Nitric Oxide Synthase Type II
-
Nitrogen Oxides
-
Prostaglandin-Endoperoxide Synthases / biosynthesis
-
Prostaglandin-Endoperoxide Synthases / genetics
-
RNA, Messenger / antagonists & inhibitors
-
RNA, Messenger / biosynthesis
-
Time Factors
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Culture Media
-
Drug Combinations
-
Hydrazines
-
Inflammation Mediators
-
Interleukin-6
-
Isoenzymes
-
Lipopolysaccharides
-
NF-kappa B
-
Nitrogen Oxides
-
RNA, Messenger
-
Nitric Oxide
-
1,1-diethyl-2-hydroxy-2-nitrosohydrazine
-
Arginine
-
Nitric Oxide Synthase
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
NG-Nitroarginine Methyl Ester